- From: M. Scott Marshall <mscottmarshall@gmail.com>
- Date: Wed, 13 Oct 2010 15:43:28 +0200
- To: HCLS <public-semweb-lifesci@w3.org>
Lilly recently halted development of of the Alzheimer's drug "semagacestat" because it was making patients worse in two late stage clinical trials. This type of knowledge seems like very valuable information to researchers in Alzheimer's. However, in recent searches of http://clinicaltrials.gov such as http://clinicaltrials.gov/ct2/results?term=semagacestat, it seems that the news hasn't been incorporated into the data on the website. However, assuming that it had been added, I am curious how 'cancelled clinical trials' can be found in the linked data. Has anyone looked at this? http://prescriptions.blogs.nytimes.com/2010/08/17/lilly-halts-alzheimers-drug-trial/?scp=2&sq=alzheimer's%20disease&st=cse Another example of contradiction/refutation, this time found in PubMed, is that Metformin apparently doesn't work (only) along the pathways that previous research indicated: "Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state" http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898585/ Has anyone seen a way to deal with conflicting information like this in text mining? If we were to represent this information in RDF, could we do it in such a way that we could observe the change of the Metformin association with LKB1/AMPK pathways over time in the literature? Cheers, Scott P.S. Oktie - It is pure coincidence that the first example is from clinical trials. :) -- M. Scott Marshall, W3C HCLS IG co-chair Leiden University Medical Center / University of Amsterdam http://staff.science.uva.nl/~marshall
Received on Wednesday, 13 October 2010 13:44:01 UTC